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Secretin receptor-coupled receptors has been proposed to affect receptor function and regulation;
however, little is known about the molecular nature of such complexes. We previously utilized
bioluminescence resonance energy transfer (BRET) to demonstrate that the prototypic Family B secretin
receptor can form oligomers. We now explore the order of oligomerization present utilizing unique
bimolecular ﬂuorescence complementation and energy transfer techniques. The non-ﬂuorescent carboxyl-
terminal and amino-terminal halves of yellow ﬂuorescent protein (YFP) were fused to the carboxyl terminus
of the secretin receptor. These constructs bound secretin normally and signaled in response to secretin like
wild type receptor. When co-expressed on COS cells, these constructs physically interacted to yield typical
YFP ﬂuorescence in biosynthetic compartments and at the plasma membrane, reﬂecting receptor homo-
dimerization. However, the addition of another potential partner in form of Rlu- or CFP-tagged secretin
receptor yielded no signiﬁcant BRET or FRET signal, respectively, under conditions in which intact YFP-tagged
secretin receptor yielded such a signal. Absence of higher-order receptor oligomers was further conﬁrmed
using saturation BRET techniques. Absence of signiﬁcant resonance transfer to the secretin receptor homo-
dimer was true for carboxyl-terminally-tagged secretin receptor, as well as for receptor incorporating the
transfer partner into each of the three distinct intracellular loop domains. These results suggest that the
secretin receptor can exist only as a structurally-speciﬁc homo-dimer, without being present as higher-order
oligomers.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
Oligomerization has been reported to exist for many guanine
nucleotide-binding protein (G protein)-coupled receptors (GPCRs),
based on co-immunoprecipitation and resonance energy transfer
studies [1]. While these approaches can establish molecular associa-
tions, they have typically not distinguished dimers from higher-order
oligomers. These studies have even been criticized as possibly
reﬂecting random associations of laterally mobile receptors in the
plasma membrane or aggregation of receptors, rather than represent-
ing distinct, functionally important complexes [2], although this
criticism has itself been debated [3]. There is not yet broad agreement
regarding when physiologically signiﬁcant GPCR oligomerization
might occur and what its functional impact might be [4].energy transfer; CFP, cyan
ergy transfer; HSecR, human
enilla luciferase; YFP, yellow
l Institutes of Health, DK46577
l rights reserved.Current understanding of GPCR oligomerization varies consider-
ably among the major structural groups within this superfamily. Best
understood is the smallest group of GPCRs that belong to Family C and
have very large extracellular amino-terminal domains. The metabo-
tropic glutamate receptor and the calcium-sensing receptor are
known to be present as covalent dimers that form through distinct
associations between these domains, as documented by crystal
structures [5,6]. The largest group of GPCRs that belong to Family A
have been extensively reported to associate with themselves and with
each other, but many questions remain unresolved regarding the
nature and functional importance of such complexes [1–4,7–9].
Understanding of the oligomerization of Family B GPCRs is even
more limited, with a relatively small number of reports in the current
literature [10–12].
This study focuses on a prototypic Family B GPCR, the secretin
receptor. Based on BRET (bioluminescence resonance energy transfer)
and FRET (ﬂuorescence resonance energy transfer) studies, this
receptor has been reported to be present in the plasma membrane
as constitutive homo-oligomers that are not affected by binding
agonist ligands [11]. Additionally, the secretin receptor is capable of
associating with other members of Family B to form hetero-oligomers
[11]. Recent reports examining themolecular basis of secretin receptor
oligomerization ruled out contributions of its amino-terminal and
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segment four of this receptor as an important contributor to its homo-
oligomerization [14]. Transmembrane segment four mutants that
disrupted secretin receptor oligomerization were shown to be
functionally distinct from wild type receptor, having reduced
agonist-stimulated cAMP responses [14]. These data suggest the
functional importance of secretin receptor oligomeric complexes and
the likelihood that these are structurally distinct [14–16].
In the current work, we have utilized bimolecular ﬂuorescence
complementation to further characterize the nature of secretin
receptor complexes and have deﬁned them to represent receptor
dimers, and not higher-order oligomers. Such homo-dimeric com-
plexes provide the important potential for allosteric modulation,
ligand cooperativity, and differential effects mediated by the primary
and secondary protomer [17,18]. Since Family B GPCRs contain several
very important potential drug targets, it will be critical to explore
whether this theme is consistent throughout the family and might
also be applicable to other structurally-related receptors.
2. Materials and methods
2.1. Receptor constructs
Tagged human secretin receptor (HSecR) and human Type B
cholecystokinin receptor (hCCKBR) constructs were prepared in
pcDNA3.0 eukaryotic expression vector. These included receptor
constructs with cyan ﬂuorescent protein (CFP), renilla luciferase
(Rlu), and yellow ﬂuorescent protein (YFP) or its amino-terminal orFig. 1. Morphologic localization of YN- and YC-tagged secretin receptor constructs. Sho
localization of HA-tagged secretin receptors expressed on the surface of non-permeabilized
tagged with non-ﬂuorescent YFP fragments were able to trafﬁc normally to the plasma mecarboxyl-terminal fragments, YFP (1–158) (YN) or YFP (159–238) (YC)
(kindly provided by Dr. C. Berlot, Geisinger Clinic, Danville, PA),
respectively, at the receptor carboxyl terminus. Additional constructs
having Rlu inserted into the ﬁrst (position 513), second (position 735),
and third (position 993) intracellular loops of the secretin receptor
were also prepared, following the strategy previously utilized to
prepare analogous CFP-labeled constructs [19]. Rlu-tagged Gαs was
prepared by mutagenesis of Gαs-YFP (also provided by Dr. C. Berlot).
All sequences were conﬁrmed by direct DNA sequencing.
2.2. Cell culture and transfections
COS cells were used for the transient expression of secretin
receptor constructs for receptor binding, cAMP measurement,
immunostaining, BRET and FRET studies. Twenty-four h before
transfection, cells were plated in 10 cm tissue culture dishes at a
density of 0.5 million cells/dish and cultured in Dulbecco's Modiﬁed
Eagle's Medium (DMEM) supplemented with 5% Fetal Clone II
(Hyclone laboratories, Logan, UT). Cells were transfected with
approximately 3 μg of total DNA per dish using the diethylaminoethyl
(DEAE)-dextran method [11]. Assays were performed 48–72 h later.
For morphological FRET and immunostaining studies, the transfected
cells were lifted and replated onto coverslips 24 h before study.
2.3. Microscopy
Morphologic techniques were utilized to establish correct trafﬁck-
ing of the receptor constructs, as well as their ﬂuorescence charac-wn are representative confocal immunoﬂuorescence images illustrating cell surface
COS cells, as indicated. Similar to wild type secretin receptor, the receptor constructs
mbrane. Bar, 25 μm.
Table 1
Binding and biological activity characteristics of tagged secretin receptor constructs
expressed in intact COS cells
Receptor constructs Ki (nM) Bmax (×103) sites/cell cAMP response EC50 (nM)
HSecR-YFP 3.7±0.4 70.7±12.9 1.31±0.31
HSecR-YN 2.5±0.8 61.5±21.1 1.36±0.37
HSecR-YC 3.5±0.8 81.6±38.5 1.27±0.68
HSecR-YN and HSecR-YC 2.2±0.7 67.5±20.7 1.20±0.16
Data are expressed as means±S.E.M of values from 3–4 independent experiments
performed in duplicate.
Fig. 2. Binding and biological characteristics of tagged secretin receptor constructs expressed on intact, non-permeabilized COS cells. Shown are secretin competition-binding curves
(left panel) and secretin-stimulated cAMP responses (right panel) of cells expressing wild type receptor or co-expression of secretin receptors tagged with YN and YC at the carboxyl
terminus. See Table 1 quantitative analysis of these data. Data represent means±S.E.M. of 3 to 4 independent assays performed in duplicate.
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utilized HA-tagged receptor constructs and anti-HA immunoﬂuores-
cence, as we have described [20]. Transfected COS cells seeded onto
25-mm coverslips were washed with phosphate-buffered saline (PBS)
and ﬁxed in 2% (w/v) paraformaldehyde in PBS for 15 min. Non-
speciﬁc antibody recognition sites were blocked using 1% (v/v) normal
goat serum. Incubations with primary antibody (mouse anti-HA
epitope, 1:500) and secondary antibody (Rhodamine Red X-labeled
goat anti-mouse antibody, Invitrogen, Carlsbad, CA, 1:500) were
carried out in a humidiﬁed chamber for 1 h. Cells were then washed
three times with PBS before being mounted on a microscopic slide
using Vectashield. Immunoreactivity was visualized with a Zeiss LSM
510 confocal microscope (excitation, 543 nm argon laser; emission,
LP550 ﬁlter; pinhole diameter 2.6 airy units, Plan-Apochromat 63X/
1.4NA oil).
Transfected COS cells were also directly evaluated for YFP
ﬂuorescence using a Zeiss LSM 510 confocal microscope (Thornwood,
NY) with the following settings: excitation, 488 nm argon laser;
emission, LP505 ﬁlter; pinhole diameter 2.6 airy units, Plan-
Apochromat 63X/1.4NA oil. Images underwent background subtrac-
tion and were assembled using Adobe Photoshop 7.0 (Mountain View,
CA). Fluorescent receptor expression at the cell surface was quantiﬁed
using Metamorph 6.3 (Molecular Devices, Sunnyvale, CA).
2.4. Receptor binding assays
Secretin receptor binding studies were performed in intact,
transfected COS cells. Receptor-expressing COS cells were mixed
with 2 pM (125I-Tyr10)secretin-27 radioligand (approximately
20,000 cpm/tube, speciﬁc radioactivity 2000 Ci/mmol) in Krebs–
Ringer/HEPES (KRH) medium containing 25 mM HEPES, pH 7.4,
104 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM KH2PO4, and 1.2 mM
MgSO4, with 0.01% soybean trypsin inhibitor, 1 mM phenylmethyl-
sulfonyl ﬂuoride, and 0.2% bovine serum albumin, in the absence or
presence of increasing concentrations (0 to 1 μM) of unlabeled
secretin for 1 h at room temperature. Bound and free radioligandwere
then separated by centrifugation and repeated washing with ice-cold
medium. Receptor-bound radioactivity was quantiﬁed using a γ
spectrometer. Binding data were analyzed using the LIGAND program
[21] and were plotted using the nonlinear least-squares curve-ﬁtting
routine in Prism (GraphPad 3.0, San Diego, CA).
2.5. cAMP assays
Agonist-stimulated cAMP accumulation in receptor-bearing COS
cells was quantiﬁed using the LANCE assay from PerkinElmer
(Wellesley, MA), which was performed in 384-well white Optiplates
with a 2103 Envision plate reader, as we previously described [14].
COS cells expressing receptor constructs in KRH medium containing
0.2% bovine serum albumin, 0.01% soybean trypsin inhibitor, 0.1%bacitracin, and 1 mM 3-isobutyl-1-methylxanthine were stimulated
for 30 min at 37 °C with increasing concentrations of secretin (1 pM to
1 μM). The incubation was terminated by adding chilled 6% perchloric
acid and the pH of the supernatant was adjusted to 6.0 using 30%
KHCO3. Equal volumes of sample (6 μl of cell supernatant) were mixed
with Alexa Fluor® 647-labeled cAMP antibodies in KRH medium
containing 0.1% bovine serum albumin and incubated for 30 min at
room temperature. The reaction mixture was then mixed with 12 μl of
detection mixture containing europium-labeled streptavidin and
biotin-cAMP and further incubated for 1 h. Time-resolved FRET
signals were measured after excitation at 340 nm, with emission
quantiﬁed at 615 and 665 nm wavelengths.
2.6. BRET studies
BRET studies were performed using COS cells that had been
transfected using 3 μg of receptor DNA per plate, divided equally
among two or three constructs for each condition. Assays were
performed for aliquots of approximately 25,000 cells per well in 96-
well white Optiplates, as described previously [14]. The BRET assay
was initiated by adding the cell-permeant Renilla luciferase-speciﬁc
substrate, coelenterazine h (Biotium, Hayward, CA), to the cell
suspension to yield a ﬁnal concentration of 5 μM. The BRET signal
was collected using the 2103 Envision ﬂuorescence plate reader
(PerkinElmer, Wellesley, MA) set up with the b700 nm mirror and
with emission ﬁlter sets for luminescence (460 nm, bandwidth 25 nm)
and ﬂuorescence (535 nm, bandwidth 25 nm). The BRET ratio was
calculated based on the ratio of ﬂuorescence and luminescence
emission [14].
Saturation BRET experiments were performed, as described
previously [14]. For these, COS cells were transfected with a ﬁxed
amount of Rlu-tagged construct (1.0 μg DNA/dish) and with increasing
amounts of YFP-tagged construct (0.3 μg to 6 μg DNA/dish). Assays
were performed 48 h after transfection. Fluorescence and lumines-
cence intensities were quantiﬁed using speciﬁed ﬁlter sets in
representative aliquots of the same populations of cells utilized in
each set of BRET studies. Background-subtracted values were used to
calculate the acceptor-donor ratios that were plotted relative to the
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quality-of-ﬁt based on R2 values using Prism 3.0. When a single phase
exponential curvewas found to represent a signiﬁcantly better ﬁt than
the linear function (F test p valueb0.05), it was utilized to calculate the
BRETmax and BRET50 values.
Because of the potential impact of high, potentially unphysiologic
levels of receptor expression in this type of oligomerization study, we
also performed additional saturation BRET studies with low levels of
receptor expression, in the physiologic or even sub-physiologic range.
In this case, COS cells were transfected with a ﬁxed amount of Rlu-
tagged receptor construct (0.05 μg DNA/dish) and with increasingFig. 3. Bimolecular ﬂuorescence complementation. Shown are representative confocal ﬂuore
expression of each construct was established by saturable radioligand-binding analysis. Im
secretin receptor, supporting secretin receptor homo-dimerization. Absence of ﬂuorescence
support the structural speciﬁcity of the secretin receptor interaction. Bar, 25 μm.amounts of YFP-tagged receptor construct (0.03 μg to 0.6 μg DNA/
dish). Assays were performed 48 h after transfection. Results were
plotted as ratios of YFP ﬂuorescence to Rlu luminescence.
2.7. Fluorescence spectroscopy
Steady-stateﬂuorescence intensitieswere collected in a Fluoromax-
3 ﬂuorometer (SPEX industries, Edison, NJ) at 25 °C using a 1 ml quartz
cuvette. Fluorescence resonance energy transfer (FRET) data were
acquired by excitation at 433 nmwith emission collected from 450 nm
to 600 nm. YFP ﬂuorescence was quantiﬁed from 500 nm to 600 nmscence images of COS cells expressing various receptor constructs, as indicated. Surface
ages support physical interaction between YN-tagged secretin receptor and YC-tagged
when YN and YC were tagged to structurally-distinct receptors that were co-expressed
Fig. 4. Fluorescence spectra and anisotropy of receptor tagged with fragments of YFP. Shown are ﬂuorescence emission spectra (left panel) and steady state ﬂuorescence anisotropy
data (right panel) for intact YFP-tagged secretin receptor and YFP reconstituted from its fragments attached to secretin receptor constructs that were co-expressed in COS cells. The
cells were excited at 480 nm and emission was acquired from the region between 500 nm and 600 nm. Data represent means±S.E.M. of values from four independent experiments
performed in duplicate.
Fig. 5. BRET assays. Shown are BRET signals generated from COS cells expressing Rlu-
tagged secretin receptor with YFP-tagged or co-expressed YN- and YC-tagged secretin
receptor constructs. For each condition, a total of 3 μg of DNA was utilized, divided
equally among the noted constructs. Shown also are BRET signals obtained from cells
expressing YFP-tagged or YN- and YC-tagged secretin receptor constructs with Gαs-Rlu
constructs. As a negative control, the BRET signal between Gαs-Rlu and YFP-tagged
Type B cholecystokinin receptor was not found to be signiﬁcant. The shaded area
represents the non-speciﬁc BRET signal that can be generated between Rlu-tagged
secretin receptor and YFP-tagged structurally-unrelated Type B cholecystokinin
(CCKBR) receptor. BRET ratios above this were considered to be signiﬁcant. Data are
presented as means±S.E.M. of ﬁve independent experiments.⁎pb0.05, indicate BRET
signals signiﬁcantly above background.
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utilized to correct for background ﬂuorescence. Anisotropy measure-
ments at room temperature were recorded using a Fluoromax-3
ﬂuorometer equipped with an automatic polarizer and a thermo-
statically-regulated cuvette holder, as we described previously [22].
2.8. Morphological FRET microscopy
Morphological FRET imaging was performed using an Axiovert
200M inverted epiﬂuorescence microscope (Carl Zeiss, Thornwood,
NY) having ﬁxed ﬁlter set (Chroma Technology Corp., Brattleboro, VT)
for CFP (excitation, 436/20 nm; dichroic mirror, 455 dclp; and
emission, 480/40 nm), YFP (excitation, 500/20 nm; dichroic mirror,
Q515 lp; and emission, 535/30 nm), and FRET (excitation, 436/20 nm;
dichroic mirror, 455 dclp; and emission, 535/30 nm), as described
previously [11]. Raw images were collected separately for each of the
channels with constant exposure times using amonochromatic ORCA-
12ER CCD camera (Hamamatsu, Bridgewater, NJ) with automated
QED-InVivo 2.039 acquisition software (Media Cybernetics Inc., Silver
Spring, MD). Donor and acceptor bleed-through coefﬁcient into the
FRET channel were calculated and corrected [11] using the sensitized-
emission method provided by Metamorph version 6.3 (Molecular
Devices, Sunnyvale, CA). Corrected FRET represents FRETc=FRET-
(B⁎CFP)-(A⁎YFP) where FRET, CFP, and YFP represent blank (back-
ground signal within the respective images)-subtracted images
collected in the corresponding channels. B and A are the bleed-
through coefﬁcients. Grey scale digital images were background-
subtracted and then assembled into ﬁgures using Adobe Photoshop
7.0 (Mountain View, CA).
3. Results
3.1. Expression of secretin receptor constructs
Secretin receptor constructs tagged at the carboxyl terminus with
YFP or its fragments, YN (YFP (1–158)) and YC (YFP (159–238)), were
expressed well in COS cells and trafﬁcked normally to the cell surface.
Shown in Fig.1 are images documenting immunolabeling of HA-tagged
receptor constructs with these carboxyl-terminal tags appearing at the
cell surface. The functional characteristics of these constructs are
shown in Fig. 2 and quantiﬁed in Table 1. They bound secretin normally
and had normal cAMP responses to secretin stimulation.
3.2. Bimolecular ﬂuorescence complementation evidence of secretin
receptor homo-dimerization
Consistent with the previous demonstration of secretin receptor
oligomerization using BRET technology, the bimolecular ﬂuorescence
complementation approach documented the ability of the non-ﬂuorescent carboxyl-terminal and amino-terminal fragments of YFP
attached to secretin receptor constructs to physically interact and to
become ﬂuorescent, with characteristics typical of intact YFP. Fig. 3
shows confocal images of YFP ﬂuorescence from tagged secretin
receptor constructs expressed in COS cells. No ﬂuorescence was
observed for either of the YFP fragments expressed alone or for the
complementary fragments co-expressed on the cell surface attached to
the secretin receptor and to the structurally-unrelated Type B
cholecystokinin (CCK) receptor. The complementary fragments of
YFP attached to the carboxyl terminus of the human Type B CCK
receptor were functionally similar to untagged wild type receptor in
regard to agonist-stimulated calcium responses (EC50 values (nM),
HCCKBR, 0.54±0.14; HCCKBR-YN, 0.52±0.07; HCCKBR-YC, 0.45±0.06).
When the complementary YFP fragments were both attached to
secretin receptor constructs, typical YFP ﬂuorescence was observed at
the cell surface. It is important to note that this technique was utilized
to determine only whether a signiﬁcant BRET signal above background
could be produced, and the intensity of the signal should not be
compared with the two molecule BRET studies. This relates to the
various combinations of non-productive as well as productive pairings
that can occur, with this even more complex in the bimolecular
ﬂuorescence complementation experiments, making quantitative
comparisons between these techniques problematic. It is also
important to recognize that bimolecular complementation may
occur co-translationally, and due to the strong energy of association,
that this may be functionally irreversible as the dimeric complex
Fig. 6. Saturation BRETanalysis. Shown in panels A and B are BRET saturation curves plotted as ratios of YFP ﬂuorescence to Rlu luminescence that were obtained using a ﬁxed amount
of donor (1.0 μg DNA/dish) and increasing amounts of acceptor (0.3 μg to 6 μg DNA/dish), as indicated. HSecR-Rlu/HSecR-YFP generated an exponential curve that increased until
values reached saturation and the HSecR-Rlu/HSecR-YN/HSecR-YC yielded a curve that was not different from a linear ﬁt to the data. Similarly, Gαs-Rlu/HSecR-YFP or Gαs-Rlu/HSecR-
YN/HSecR-YC yielded an exponential curve that reached saturation, while the Gαs-Rlu/HCCKBR-YFP condition produced data that was adequately ﬁt to a line. Data are represented as
means±S.E.M of four independent experiments. ⁎pb0.05 indicates a BRET signal signiﬁcantly above background.
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membrane. This should not represent a problem in the current studies,
since data from studies using intact complementarily-tagged secretin
receptor constructs clearly demonstrate an oligomeric state of these
constructs at the cell surface.
Fig. 4 illustrates the ﬂuorescence emission spectra of intact YFP
attached to the secretin receptor and YFP reconstituted from its non-
ﬂuorescent amino-terminal and carboxyl-terminal fragments
attached to secretin receptor constructs that are co-expressed. The
background-subtracted ﬂuorescence intensities (×103) at 525 nm
(peak emission) represented 463±24 for HSecR-YFP and 260±11 forFig. 7. Levels of cell surface expression of secretin receptor. Shown in panel A are representat
levels of receptor expression with increasing amounts of DNA, with the predominant locat
ﬂuorescence signal that represents YFP-tagged receptor at the cell surface in the type of t
approximately 500 sites per cell to 20,000 sites per cell. Data are presented as means±S.E.Mthe condition in which the amino-terminal and carboxyl-terminal
non-ﬂuorescent fragments of YFP attached to the secretin receptor
were co-expressed. Fluorescence anisotropy measurements of intact
and reconstituted forms of YFP are also shown in Fig. 4. These
document adequate mobility with sufﬁcient rotational freedom of this
ﬂuorescence acceptor for it to be valid in energy transfer studies.
3.3. BRET studies of higher-order receptor oligomerization
We utilized resonance transfer combined with bimolecular
ﬂuorescence complementation to examine whether secretin receptorive confocal images of YFP-tagged HSecR (acceptor in BRET studies) revealing increasing
ion of receptor on the cell surface. Shown in panel B is the quantitative analysis of the
ransfection experiment shown in panel A. Levels of receptor expression ranged from
of four independent experiments. Bar, 25 μm.
Fig. 9. BRET studies utilizing varied positions of the donor. Shown are the BRET signals
generated with donor situated within intracellular loops 1, 2, and 3 of the secretin
receptor. Each was co-expressed with HSecR-YFP or with the combination of HSecR-YN
and HSecR-YC. The total amount of DNA used for each transfection was 3 μg, divided
equally among the noted constructs. No signiﬁcant BRET signal was obtained with any
of the receptor constructs expressed in combination with HSecR-YN and HSecR-YC. The
shaded area represents the non-speciﬁc BRET signal that can be generated between Rlu-
tagged secretin receptor and YFP-tagged structurally-unrelated Type B cholecystokinin
(CCKBR) receptor. Values represent means±S.E.M of data from four independent
experiments. ⁎pb0.05 indicates a BRET signal signiﬁcantly above background.
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molecules involved in the complementation studies. In this approach,
Rlu (Renilla luciferase)-tagged secretin receptor was utilized as
potential donor and YFP reconstituted from its fragments (YN and
YC) that were tagged to associated secretin receptor constructs was
utilized as acceptor. A positive control represented intact YFP attached
to the secretin receptor as acceptor. Fig. 5 shows a clear BRET signal
between Rlu- and intact YFP-tagged secretin receptors, but absence of
a BRET signal when the Rlu-tagged receptor was co-expressed with
the pair exhibiting bimolecular ﬂuorescence complementation. To
validate the ability to combine bimolecular ﬂuorescence complemen-
tation with BRET to demonstrate the interaction of three molecules,
we utilized the established association between the secretin receptor
and the heterotrimeric G protein, Gαs. The secretin receptor
constructs exhibiting bimolecular ﬂuorescence complementation
were able to effectively pair with Rlu-tagged Gαs to yield a signiﬁcant
BRET signal in this assay. This was not different from the signal coming
from intact YFP-tagged secretin receptor co-expressed with this Rlu-
tagged G protein. Of note, no signiﬁcant BRET signal was observed
when the Rlu-tagged Gαs was co-expressed with YFP-tagged human
Type B cholecystokinin receptor (a Gq-coupled receptor).
The static BRET results were conﬁrmed further with saturation BRET
experiments (Fig. 6). Unlike the intact YFP-tagged secretin receptor co-
expressed with the Rlu-tagged receptor that yielded a saturable signal
reaching an asymptote, the pair of constructs exhibiting bimolecular
ﬂuorescence complementation co-expressed with the Rlu-tagged
receptor only generated a linear signal reﬂecting non-speciﬁc bystander
interactions [14]. Similarly, the static BRET signal between Rlu-tagged
Gαs and YFP-tagged secretin receptor or pairs of constructs exhibiting
bimolecular ﬂuorescence complementation generated a saturable BRET
signal that reached an asymptote (Fig. 6B).
We also performed two series of BRET studies with low
concentrations of secretin receptor expression to be certain that
these receptor association observations would also be relevant to
physiologic levels of receptor expression [14]. For these experiments,
cell surface receptors were quantiﬁed morphologically using densito-
metric analysis of ﬂuorescence in that compartment representing
YFP-receptor expression as shown in Fig. 7, as well as by using
quantitative secretin radioligand-binding analysis. Indeed, in the
range of these experiments, from approximately 500 to 20,000
receptors per cell, the Pearson correlation coefﬁcients clearly demon-
strated a linear relationship between the amount of receptor construct
DNA utilized and receptor expression, both at the level of cell surface
ﬂuorescence and at the level of direct quantitation of binding sites inFig. 8. Saturation BRET analysis with sub-physiologic levels of receptor expression.
Shown are BRET saturation curves plotted as ratios of YFP ﬂuorescence to Rlu
luminescence, utilizing 0.05 μg Rlu-tagged receptor construct DNA/dish and 0.03 μg to
0.6 μg YFP-tagged receptor construct DNA/dish. At levels of donor receptor expression
in the range of 500 sites per cell, HSecR-Rlu and HSecR-YFP generated a curve that
reached saturation, while the HSecR-Rlu and HSecR-YN and HSecR-YC condition best ﬁt
a linear relationship that did not saturate. This is similar to what was observed in Fig. 6
under conditions with higher levels of receptor expression. Data are presented as
means±S.E.M of four independent experiments.intact cells. These values were r=0.96, pb0.001 for cell surface
ﬂuorescence and r=0.92, pb0.003 for binding sites.
As further evidence for the relevance of these ﬁndings to
physiologic levels of receptor expression, saturation BRETexperiments
analogous to those illustrated in Fig. 6 were also performed with low
levels of receptor expression. In this case, COS cells were transfected
with only 0.05 μg Rlu-tagged receptor construct DNA/dish and with
0.03 μg to 0.6 μg YFP-tagged receptor construct DNA/dish. The results
of these experiments are shown in Fig. 8. These data demonstrate that
Rlu- and YFP-tagged secretin receptor constructs yielded a saturable
BRET signal that reached an asymptote, while the expression of Rlu-
tagged secretin receptor with secretin receptor constructs exhibiting
bimolecular complementation yielded only a low level, non-saturable
signal.
Because of the possibility of less-than-optimal geometry and/or
distances for energy transfer when the donor Rlu was at the carboxyl
terminus of the secretin receptor, we also performed analogous
studies with secretin receptor constructs in which the Rlu was
inserted into each of the three distinct intracellular loop regions of
that receptor. Similar to the carboxyl-terminal location, none of the
loop constructs yielded a signiﬁcant BRET signal with the pair of
secretin receptor constructs exhibiting bimolecular ﬂuorescence
complementation (Fig. 9).
3.4. Morphological FRET microscopy
This morphological technique further conﬁrmed the absence of
higher-order oligomerization of the secretin receptor beyond the
dimerization reﬂected in the YFP ﬂuorescence exhibited at the cell
surface after co-expression of YN- and YC-tagged secretin receptors
(Fig. 10). Unlike the clear FRET signal at the plasma membrane coming
from expression of intact YFP-tagged secretin receptor with CFP (cyan
ﬂuorescent protein)-tagged receptor, expression of the pair of secretin
receptor constructs exhibiting ﬂuorescence complementation along
with the CFP-tagged receptor yielded no signiﬁcant FRET signal.
4. Discussion
Oligomerization of GPCRs has been implicated in their normal
biosynthesis and trafﬁcking, in the selectivity and afﬁnity of ligand
binding, and in their regulation and desensitization [1,18,23,24].
Insight into the molecular mature of oligomeric complexes should
Fig. 10. FRET microscopy. Shown are representative microscopic images of COS cells expressing CFP-and YFP-tagged HSecR or CFP-tagged HSecR along with YN- and YC-tagged
secretin receptor constructs. Images shown in the left, middle and right column represent background-subtracted, corrected CFP images, background-subtracted, corrected YFP
images, and corrected FRET images, respectively. The wild type receptor exhibited a signiﬁcant FRET signal at the cell surface (arrowheads) and in intracellular compartments. There
was no signiﬁcant FRET signal generated from co-expression of CFP-tagged secretin receptor with the YN- and YC-tagged secretin receptor constructs. The images shown are
representative of data from four similar experiments. Bar, 25 μm.
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these processes. It is unlikely that non-speciﬁc receptor aggregates or
high order oligomers provide a distinct structural mechanism for
these functional events. In contrast, the structurally-speciﬁc secretin
receptor dimers that are supported by the current work provide a
basis for further study of linkage between structure and function.
Bimolecular ﬂuorescence complementation approaches provide a
powerful method for the direct demonstration of the physical
interaction between two tagged molecules [25,26]. In this technique,
yellow ﬂuorescent protein (YFP) has been divided into two compo-
nent regions, neither of which is ﬂuorescent by itself. When the two
regions are able to physically associate with the correct spatial
geometry and dipole orientation, the ﬂuorescence typical of intact YFP
protein can be reconstituted. Indeed, we have demonstrated that this
occurs when these two portions of YFP are attached to the carboxyl
terminus of the secretin receptor and these constructs are co-
expressed in the same cell. This reﬂects the homo-dimerization of
the secretin receptor.It is of particular interest that a third copy of the secretin receptor
appears to be unable to associate with an intact homo-dimer of the
same receptor. This was demonstrated using BRET methodology, with
the third copy of the receptor labeled at its carboxyl-terminal tail, as
well as within each of its three distinct intracellular loop domains. If a
higher-order oligomer could be formed, one would expect at least one
of these positions to yield a signiﬁcant BRET signal. Additionally, the
static BRET results were evaluated with saturation BRET methodology
and found to conﬁrm this interpretation. Further, morphological FRET
was also utilized and found to yield the same conclusion that the
secretin receptor forms homo-dimers at the cell surface, without
evidence for higher-order oligomers. An important positive control
demonstrated that Gαs could elicit a positive BRET signal when
expressed with the intact homo-dimeric secretin receptor, with this
signal not different from the signal it generates with a single secretin
receptor construct taggedwith intact YFP. This control was also shown
to be speciﬁc for Gs-coupled receptors, with no signiﬁcant BRET signal
observed for a Gq-coupled control receptor.
2563K.G. Harikumar et al. / Biochimica et Biophysica Acta 1778 (2008) 2555–2563The implications of a speciﬁc dimeric structure could be quite
signiﬁcant. Recent work has demonstrated that the amino terminus
and carboxyl terminus of the secretin receptor do not contribute to its
oligomerization [13]. Similarly, competition with each of the seven
transmembrane segment peptides revealed that only transmembrane
segment four effectively competes for secretin receptor oligomeriza-
tion [14]. When coupled with the current data, these observations
suggest that the homo-dimeric secretin receptor complex forms
between helix four of one protomer and helix four of a second
protomer. This supports a high degree of structural speciﬁcity of this
dimeric complex. It is not yet clear whether this might also exist for
other Family B GPCRs. The helical bundle of Family B GPCRs is
predicted to be quite distinct from that of the better studied Family A
GPCRs containing rhodopsin and the β2-adrenergic receptor [27,28].
With the transmembrane segments likely most important for the
oligomerization of the secretin receptor [10,13,14], a distinct mechan-
ism for this group of GPCRs is quite likely.
We already know that secretin receptor homo-oligomers are
stable, forming constitutively and not being disrupted by agonist
binding [11]. We also know that disruption of the oligomeric secretin
receptor complexes has functional implications, with reduced cAMP
responsiveness [14]. Now that we have learned that this represents a
structurally-speciﬁc homo-dimer, rather than a higher-order oligo-
mer, it becomes easier to envision this as facilitating G protein
coupling for this prototypic Family B GPCR. It is even possible that the
stoichiometry of receptor to G protein could be two to one, as
suggested in a recent report [29], while several other studies have
clearly demonstrated single Family A GPCRs as being sufﬁcient for G
protein coupling [30,31]. Nevertheless, Family B GPCRsmay be distinct
and unique in this regard. Insight into this will be very important as
we begin to examine the structural basis of allosteric modulation,
ligand cooperativity, and even the possibility of having distinct
functional implications of occupying the primary and secondary
protomer of this homo-dimeric complex.
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